EvidenceHunt
PrivateLast Round
Seed
Feb 27, 2025
Total Funding Raised
$1.26M
Company Overview
EvidenceHunt is an enterprise software company that provides an AI-powered research platform for analyzing medical literature, clinical guidelines, and internal protocols.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Vertical SaaS, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EvidenceHunt Comparables
Compare EvidenceHunt with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioSkepsis | 81% | |
| Rayyan | 79% | |
| DistillerSR Inc. | 78% | |
EvidenceHunt Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 27, 2025 |
EvidenceHunt Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keen Venture Partners | Seed |
| Slimmer AI | Seed |
| DFF Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 29, 2026
Monthly visitors increased 67% MoM.
- Jun 4, 2025
Grew 60% QoQ, from 5 to 8 employees.
EvidenceHunt Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EvidenceHunt's valuation, stock price, and market status.